Open AccessCardiovascular Outcomes in Patients With Primary Aldosteronism After Treatment
Author(s) -
Cristiana Catena
Publication year - 2008
Publication title -
archives of internal medicine
Language(s) - English
Resource type - Journals
eISSN - 1538-3679
pISSN - 0003-9926
DOI - 10.1001/archinternmed.2007.33
Subject(s) - primary aldosteronism , medicine , cardiology , spironolactone , blood pressure , aldosterone , essential hypertension , myocardial infarction , odds ratio , adrenalectomy , secondary hypertension , clinical endpoint , randomized controlled trial
Experimental and human studies demonstrate that long-term exposure to elevated aldosterone levels results in cardiac and vascular damage.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom